Photo

Photo detail

Henry Ji

Stories this photo appears in:

Sorrento Therapeutics to Acquire ACEA for $38M in Stock

BIOTECH: Antibody-Centric Company Grows

Sorrento Therapeutics (NASDAQ: SRNE) will acquire ACEA Therapeutics in a deal that offers ACEA’s equity holders approximately $38 million in common stock, the company announced on April 5.